Healthcare-Associated Infections and Prevention Programs in General Nursing versus Residential Homes—Results of the Point Prevalence Survey in Polish Long-Term Care Facilities
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. Residents Characteristics and Infections
3.2. Infection Control and Prevention Programs
4. Discussion
Strengths and Limitations of This Study
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Ethics Approval
References
- Kołpa, M.; Wałaszek, M.; Różańska, A.; Wolak, Z.; Wójkowska-Mach, J. Hospital-Wide Surveillance of Healthcare-Associated Infections as a Source of Information about Specific Hospital Needs. A 5-Year Observation in a Multiprofile Provincial Hospital in the South of Poland. Int. J. Environ. Res. Public Health 2018, 15, 1956. [Google Scholar] [CrossRef] [PubMed]
- Cassini, A.; Högberg, L.D.; Plachouras, D.; Quattrocchi, A.; Hoxha, A.; Simonsen, G.S.; Colomb-Cotinat, M.; Kretzschmar, M.E.; Devleesschauwer, B.; Cecchini, M.; et al. Burden of AMR Collaborative Group. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect. Dis. 2019, 19, 56–66. [Google Scholar] [CrossRef] [PubMed]
- Suetens, C.; Latour, K.; Kärki, T.; Ricchizzi, E.; Kinross, P.; Moro, M.L.; Jans, B.; Hopkins, S.; Hansen, S.; Lyytikäinen, O.; et al. Healthcare-Associated Infections Prevalence Study Group. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: Results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. 2018, 23, 1800516. [Google Scholar] [CrossRef] [PubMed]
- El Chakhtoura, N.G.; Bonomo, R.A.; Jump, R.L.P. Influence of Aging and Environment on Presentation of Infection in Older Adults. Infect. Dis. Clin. N. Am. 2017, 31, 593–608. [Google Scholar] [CrossRef] [PubMed]
- McGeer, A.; Campbell, B.; Emori, T.G.; Hierholzer, W.J.; Jackson, M.M.; Nicolle, L.E.; Peppler, C.; Rivera, A.; Schollenberger, D.G.; Simor, A.E.; et al. Definitions of infection for surveillance in long-term care facilities. Am. J. Infect. Control 1991, 19, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Ordinance of the Minister of Health dated 22 November 2013 on Guaranteed Benefits of Nursing and Care in the Framework of Long-Term Care. J. Laws 2022, 965.
- The Act of 12 March 2004 on social assistance. J. Laws 2023, 901.
- Map of Health Needs, Ministry of Health of the Republic of Poland. Available online: https://basiw.mz.gov.pl/mapy-informacje/mapa-2022-2026/analizy/opieka-dlugoterminowa/ (accessed on 2 January 2024).
- Health and Health Care in 2017, Central Statistical Office of Poland, Warsaw, Cracow 2018. Available online: https://stat.gov.pl/files/gfx/portalinformacyjny/pl/defaultaktualnosci/5513/1/8/1/zdrowie_i_ochrona_zdrowia_w_2017.pdf (accessed on 2 January 2024).
- Residential Social Assistance Institutions in 2017, Central Statistical Office of Poland, Warsaw. 2018. Available online: https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5487/18/2/1/zaklady_stacjonarne_pomocy_spolecznej_w_2017_roku.pdf (accessed on 2 January 2024).
- Numerical Summary of Doctors and Dentists by Field and Degree of Specialization, Supreme Chamber of Physicians, Warsaw 2017. Available online: http://www.nil.org.pl/__data/assets/pdf_file/0011/111062/Zestawienie-nr-04.pdf (accessed on 2 January 2024).
- Healthcare Personnel Statistics –Physicians, Eurostat. Available online: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Healthcare_personnel_statistics_-_physicians&oldid=460643#Healthcare_personnel (accessed on 6 December 2023).
- Healthcare Personnel Statistics—Nursing and Caring Professionals, Eurostat. Available online: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Healthcare_personnel_statistics_-_nursing_and_caring_professionals#Healthcare_personnel (accessed on 6 December 2023).
- Health at a Glance 2019 OECD INDICATORS. Available online: https://read.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2019_4dd50c09-en#page1 (accessed on 6 December 2023).
- Surveillance Report Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Long-Term Care Facilities 2016–2017, ECDC. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/healthcare-associated-infections-antimicrobial-use-long-term-care-facilities-2016-2017.pdf (accessed on 6 December 2023).
- Wojkowska-Mach, J.; Brudło, M.; Topolski, M.; Bochenek, T.; Jachowicz, E.; Siewierska, M.; Różańska, A. Antibiotic consumption in long-term care facilities in Poland and other European countries in 2017. Antimicrob. Resist. Infect. Control 2021, 10, 154. [Google Scholar] [CrossRef]
- Wójkowska-Mach, J.; Gryglewska, B.; Czekaj, J.; Adamski, P.; Grodzicki, T.; Heczko, P.B. Infection control: Point prevalence study versus incidence study in Polish long-term care facilities in 2009–2010 in the Małopolska Region. Infection 2013, 41, 1–8. [Google Scholar] [CrossRef]
- Cotter, M.; Donlon, S.; Roche, F.; Byrne, H.; Fitzpatrick, F. Healthcare-associated infection in Irish long-term care facilities: Results from the First National Prevalence Study. J. Hosp. Infect. 2012, 80, 212–216. [Google Scholar] [CrossRef]
- Ripabelli, G.; Salzo, A.; Mariano, A.; Sammarco, M.L.; Tamburro, M. Collaborative Group for HAIs Point Prevalence Surveys in Molise Region. Healthcare-associated infections point prevalence survey and antimicrobials use in acute care hospitals (PPS 2016–2017) and long-term care facilities (HALT-3): A comprehensive report of the first experience in Molise Region, Central Italy, and targeted intervention strategies. J. Infect. Public Health 2019, 12, 509–515. [Google Scholar] [CrossRef]
- Furmenti, M.F.; Rossello, P.; Bianco, S.; Olivero, E.; Thomas, R.; Emelurumonye, I.N.; Zotti, C.M. HALT3 Italian Collaborating Group. Healthcare-associated infections and antimicrobial use in long-term care facilities (HALT3): An overview of the Italian situation. J. Hosp. Infect. 2019, 102, 425–430. [Google Scholar] [CrossRef]
- Heudorf, U.; Boehlcke, K.; Schade, M. Healthcare-associated infections in long-term care facilities (HALT) in Frankfurt am Main, Germany, January to March 2011. Euro Surveill. 2012, 17, 20256. [Google Scholar] [CrossRef] [PubMed]
- Wójkowska-Mach, J.; Gryglewska, B.; Romaniszyn, D.; Natkaniec, J.; Pobiega, M.; Adamski, P.; Grodzicki, T.; Kubicz, D.; Heczko, P.B. Age and other risk factors of pneumonia among residents of Polish long-term care facilities. Int. J. Infect. Dis. 2013, 17, e37–e43. [Google Scholar] [CrossRef] [PubMed]
- Okazaki, T.; Ebihara, S.; Mori, T.; Izumi, S.; Ebihara, T. Association between sarcopenia and pneumonia in older people. Geriatr. Gerontol. Int. 2020, 20, 7–13. [Google Scholar] [CrossRef] [PubMed]
- Vignari, M. Non-ventilator health care-associated pneumonia (NV-HAP): NV-HAP, Risk Factors. Am. J. Infect. Control. 2020, 48, A10–A13. [Google Scholar] [CrossRef] [PubMed]
- Nenoff, P.; Krüger, C.; Ginter-Hanselmayer, G.; Tietz, H.-J. Mycology—An update. Part 1: Dermatomycoses: Causative agents, epidemiology and pathogenesis. J. Ger. Soc. Dermatol. 2014, 12, 188–209. [Google Scholar] [CrossRef] [PubMed]
- Nicolle, L.E. Infection prevention issues in long-term care. Curr. Opin. Infect. Dis. 2014, 27, 363–369. [Google Scholar] [CrossRef] [PubMed]
- Puto, G.; Wójkowska-Mach, J.; Wałszek, M.; Repka, I.; Różańska, A. Selected aspects of the knowledge and practice concerning hand hygiene guidelines in the context of infection control structures in hospitals and long-term care facilities—Findings of a questionnaire survey. Med. Pr. 2020, 71, 531–537. [Google Scholar] [CrossRef]
- Hammerschmidt, J.; Manser, T. Nurses’ knowledge, behaviour and compliance concerning hand hygiene in nursing homes: A cross-sectional mixed-methods study. BMC Health Serv. Res. 2019, 19, 547. [Google Scholar] [CrossRef]
- Aiello, A.E.; Malinis, M.; Knapp, J.K.; Mody, L. The influence of knowledge, perceptions, and beliefs, on hand hygiene practices in nursing homes. Am. J. Infect. Control. 2009, 37, 164–167. [Google Scholar] [CrossRef]
- Chen, H.Y.; Jean, S.S.; Lee, Y.L.; Lu, M.C.; Ko, W.C.; Liu, P.Y.; Hsueh, P.R. Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review. Front. Cell Infect. Microbiol. 2021, 11, 601968. [Google Scholar] [CrossRef]
- Lansbury, L.E.; Brown, C.S.; Nguyen-Van-Tam, J.S. Influenza in long-term care facilities. Influenza Other Respir Viruses 2017, 11, 356–366. [Google Scholar] [CrossRef] [PubMed]
- Latour, K.; Catry, B.; Broex, E.; Vankerckhoven, V.; Muller, A.; Stroobants, R.; Goossens, H.; Jans, B. European Surveillance of Antimicrobial Consumption Project Group. Indications for antimicrobial prescribing in European nursing homes: Results from a point prevalence survey. Pharmacoepidemiol. Drug Saf. 2012, 21, 937–944. [Google Scholar] [CrossRef] [PubMed]
- McClean, P.; Hughes, C.; Tunney, M.; Goossens, H.; Jans, B. European Surveillance of Antimicrobial Consumption (ESAC) Nursing Home Project Group. Antimicrobial prescribing in European nursing homes. J. Antimicrob. Chemother. 2011, 66, 1609–1616. [Google Scholar] [CrossRef] [PubMed]
- Surveillance Report Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Long-Term Care Facilities May–September 2010, ECDC. Available online: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/healthcare-associated-infections-antimicrobial-consumption-point-prevalence-survey-long-term-care-facilities-2010.pdf (accessed on 6 December 2023).
- Huang, Y.; Wei, W.I.; Correia, D.F.; Ma, B.H.M.; Tang, A.; Yeoh, E.K.; Wong, S.Y.S.; Ip, M.; Kwok, K.O. Antibiotic use for respiratory tract infections among older adults living in long-term care facilities: A systematic review and meta-analysis. J. Hosp. Infect. 2023, 131, 107–121. [Google Scholar] [CrossRef] [PubMed]
- Haayman, J.; Stobberingh, E.E. Urinary tract infections in long-term care facility residents. Future Microbiol. 2018, 13, 9–12. [Google Scholar] [CrossRef] [PubMed]
- Buhr, G.T.; Genao, L.; White, H.K. Urinary tract infections in long-term care residents. Clin. Geriatr. Med. 2011, 27, 229–239. [Google Scholar] [CrossRef] [PubMed]
- Donelli, G.; Vuotto, C. Biofilm-based infections in long-term care facilities. Future Microbiol. 2014, 9, 175–188. [Google Scholar] [CrossRef]
Parameter | All LTCF | NH | RH | NH vs. RH | |||
Number of Facilities | 24 | 12 | 12 | ||||
Total Number of Residents | 2281 | 1114 | 1167 | ||||
Descriptive Parameters According to Facilities | Q2 (Q1–Q3) | MIN–MAX | Q2 (Q1–Q3) | MIN–MAX | Q2 (Q1–Q3) | MIN–MAX | p # |
Residents, n | 71.0 | 19–389 | 47.0 (40.8–89.0) | 33–389 | 95.5 (61.8–114.8) | 19–229 | 0.453 |
(40.8–114.8) | |||||||
Men, % | 32.7 (26.0–42.7) | 0–56 | 29.4 (16.6–31.6) | 0–40 | 44.2 (36.2–52.0) | 19–56 | 0.002 |
Residents with urinary catheter, % | 8.4 (3.5–21.2) | 1–77 | 19.2 (11.9–47.7) | 1–77 | 4.3 (1.8–7.2) | 1–21 | 0.002 |
Residents with vascular catheters % | 0.0 (0.0–6.6) | 0–29 | 7.1 (3.2–11.7) | 0–29 | 0.0 (0.0–0.0) | 0–1 | <0.001 |
Residents with pressure sore, % | 7.7 (4.6–11.5) | 0–24 | 11.7 (7.7–14.7) | 2–24 | 5.4 (2.7–7.6) | 0–10 | 0.005 |
Residents with other wounds, % | 3.6 (1.9–8.5) | 0–24 | 4.3 (2.4–9.8) | 0–24 | 2.5 (1.5–5.4) | 0–11 | 0.284 |
Place/time-disoriented residents, % | 52.5 (42.1–62.6) | 7–92 | 62.9 (54.0–68.9) | 40–92 | 45.2 (34.3–52.0) | 7–62 | 0.004 |
Bedridden or on-wheel residents, % | 68.7 (44.8–85.7) | 33–100 | 86.6 (77.5–96.1) | 69–100 | 44.5 (40.7–47.4) | 33–68 | <0.001 |
Residents with incontinence, urine, or stool, % | 77.0 (58.5–88.4) | 44–100 | 86.5 (81.8–94.9) | 69–100 | 57.3 (49.1–63.6) | 44–95 | <0.001 |
Prevalence—All HAI, % | ||||||
---|---|---|---|---|---|---|
All LTCF | NH | RH | NH vs. RH | |||
Q2 (Q1–Q3) | MIN–MAX | Q2 (Q1–Q3) | MIN–MAX | Q2 (Q1–Q3) | MIN–MAX | p # |
2.6 (0.0–5.4) | 0–19 | 3.2 (2.5–4.6) | 0–17 | 0.7 (0.0–5.4) | 0–19 | 0.251 |
Infection | All LTCF | NH | RH | NH vs. RH | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n (%) @ | P85 (P75–P95) | MIN–MAX | n (%) @ | P85 (P75–P95) | MIN–MAX | n (%) @ | P85 (P75–P95) | MIN–MAX | p # | p & | |
Urinary tract infection | 27 (1.18%) | 3.2 (1.7–6.0) | 0–9 | 14 (1.26%) | 2.2 (1.4–5.8) | 0–9 | 13 (1.11%) | 3.8 (2.7–5.7) | 0–6 | 0.949 | 0.903 |
Confirmed | 7 (0.31%) | 0.0 (0.0–3.9) | 0–5 | 1 (0.09%) | 0.0 (0.0–0.6) | 0–1 | 6 (0.51%) | 1.5 (0.0–4.8) | 0–5 | 0.514 | 0.146 |
Not confirmed | 20 (0.88%) | 2.2 (1.1–3.4) | 0–9 | 13 (1.17%) | 2.1 (1.1–5.8) | 0–9 | 7 (0.60%) | 2.0 (1.1–2.7) | 0–3 | 0.918 | 0.220 |
Respiratory tract infections | 21 (0.92%) | 2.4 (1.4–3.3) | 0–4 | 14 (1.26%) | 2.2 (1.5–3.4) | 0–4 | 7 (0.60%) | 1.9 (1.0–3.2) | 0–3 | 0.765 | 0.155 |
Cold and throat infections | 3 (0.13%) | 0.0 (0.0–0.7) | 0–2 | 0 (0.00%) | 0.0 (0.0–0.0) | 0–0 | 3 (0.26%) | 0.3 (0.0–1.3) | 0–2 | 0.166 | 0.265 |
Pneumonia | 5 (0.22%) | 0.3 (0.0–2.6) | 0–3 | 3 (0.27%) | 0.2 (0.0–1.6) | 0–3 | 2 (0.17%) | 0.5 (0.0–2.1) | 0–3 | 0.965 | 0.959 |
Other respiratory tract infections | 13 (0.57%) | 0.8 (0.0–1.8) | 0–4 | 11 (0.99%) | 1.5 (0.3–2.9) | 0–4 | 2 (0.17%) | 0.0 (0.0–0.8) | 0–2 | 0.286 | 0.021 |
Skin infections | 26 (1.14%) | 1.4 (0.8–8.1) | 0–9 | 9 (0.81%) | 1.4 (0.9–4.6) | 0–9 | 17 (1.46%) | 2.4 (0.2–6.8) | 0–9 | 0.407 | 0.207 |
Skin and subcutaneous tissue, wounds | 20 (0.88%) | 1.4 (0.8–4.9) | 0–9 | 9 (0.81%) | 1.4 (0.9–4.6) | 0–9 | 11 (0.94%) | 1.8 (0.2–4.2) | 0–5 | 0.370 | 0.904 |
Fungal infections | 6 (0.26%) | 0.0 (0.0–0.0) | 0–5 | 0 (0.00%) | 0.0 (0.0–0.0) | 0–0 | 6 (0.51%) | 0.0 (0.0–2.4) | 0–5 | 0.359 | 0.047 |
Surgical site infections | 2 (0.09%) | 0.0 (0.0–0.7) | 0–1 | 0 (0.00%) | 0.0 (0.0–0.0) | 0–0 | 2 (0.17%) | 0.3 (0.0–0.9) | 0–1 | 0.166 | 0.500 |
Eyes, ears, nose, oral cavity infections | 8 (0.35%) | 0.0 (0.0–1.7) | 0–4 | 1 (0.09%) | 0.0 (0.0–0.6) | 0–1 | 7 (0.60%) | 0.6 (0.0–2.9) | 0–4 | 0.514 | 0.088 |
Conjuctivitis | 5 (0.22%) | 0.0 (0.0–0.7) | 0–3 | 0 (0.00%) | 0.0 (0.0–0.0) | 0–0 | 5 (0.43%) | 0.3 (0.0–2.0) | 0–3 | 0.166 | 0.082 |
Ears | 3 (0.13%) | 0.0 (0.0–0.9) | 0–1 | 1 (0.09%) | 0.0 (0.0–0.6) | 0–1 | 2 (0.17%) | 0.3 (0.0–0.9) | 0–1 | 0.651 | 1.000 |
Gastrointestinal infections | 8 (0.35%) | 1.4 (0.9–2.7) | 0–3 | 6 (0.54%) | 2.5 (1.7–2.9) | 0–3 | 2 (0.17%) | 0.3 (0.0–0.9) | 0–1 | 0.106 | 0.259 |
Stomach and bowel | 4 (0.18%) | 0.0 (0.0–0.9) | 0–1 | 2 (0.18%) | 0.0 (0.0–0.6) | 0–1 | 2 (0.17%) | 0.3 (0.0–0.9) | 0–1 | 0.651 | 1.000 |
C. difficile | 2 (0.09%) | 0.0 (0.0–2.3) | 0–3 | 2 (0.18%) | 0.9 (0.0–2.9) | 0–3 | 0 (0.00%) | 0.0 (0.0–0.0) | 0–0 | 0.166 | 0.459 |
Bloodstream | 1 (0.04%) | 0.0 (0.0–0.0) | 0–1 | 1 (0.09%) | 0.0 (0.0–0.6) | 0–1 | 0 (0.00%) | 0.0 (0.0–0.0) | 0–0 | 0.359 | 0.981 |
Other | 1 (0.04%) | 0.0 (0.0–0.0) | 0–2 | 1 (0.09%) | 0.0 (0.0–1.1) | 0–2 | 0 (0.00%) | 0.0 (0.0–0.0) | 0–0 | 0.359 | 0.981 |
Infection | All LTCF | NH | RH |
---|---|---|---|
n (%) ^ | n (%) ^ | n (%) ^ | |
Urinary tract infection | 27 (28.72%) | 14 (30.43%) | 13 (27.08%) |
Confirmed | 7 (7.45%) | 1 (2.17%) | 6 (12.50%) |
Not confirmed | 20 (21.28%) | 13 (28.26%) | 7 (14.58%) |
Respiratory tract infections | 21 (22.34%) | 14 (30.43%) | 7 (14.58%) |
Cold and throat infections | 3 (3.19%) | 0 (0.00%) | 3 (6.25%) |
Pneumonia | 5 (5.32%) | 3 (6.52%) | 2 (4.17%) |
Other respiratory tract infections | 13 (13.83%) | 11 (23.91%) | 2 (4.17%) |
Skin infections | 26 (27.66%) | 9 (19.57%) | 17 (35.42%) |
Skin and subcutaneous tissue, wounds | 20 (21.28%) | 9 (19.57%) | 11 (22.92%) |
Fungal infections | 6 (6.38%) | 0 (0.00%) | 6 (12.50%) |
Surgical site infections | 2 (2.13%) | 0 (0.00%) | 2 (4.17%) |
Eyes, ears, nose, oral cavity infections | 8 (8.51%) | 1 (2.17%) | 7 (14.58%) |
Conjuctivitis | 5 (5.32%) | 0 (0.00%) | 5 (10.42%) |
Ears | 3 (3.19%) | 1 (2.17%) | 2 (4.17%) |
Gastrointestinal infections | 8 (8.51%) | 6 (13.04%) | 2 (4.17%) |
Stomach and bowel | 4 (4.26%) | 2 (4.35%) | 2 (4.17%) |
C. difficile | 2 (2.13%) | 2 (4.35%) | 0 (0.00%) |
Bloodstream | 1 (1.06%) | 1 (2.17%) | 0 (0.00%) |
Other | 1 (1.06%) | 1 (2.17%) | 0 (0.00%) |
Type of Process Measures in the Facility | LTCF (%) | NH (%) | RH (%) |
---|---|---|---|
Infection prevention and control (IPC) | |||
Presence of person(s) trained in IPC | 68.0 | 100.0 | 33.3 |
Presence of infection control team | 52.0 | 91.7 | 8.3 |
Access to consultation with external experts in infection control | 52.0 | 58.3 | 50.0 |
Training on hand hygiene for personel in the facility | 72.0 | 83.3 | 58.3 |
Presence of written procedures and therapeutic recommendations | |||
Access to written procedure concerning work with patients infected or colonized with MDRO | 64.0 | 83.3 | 50.0 |
Access to written procedures on hand hygiene | 100.0 | 100.0 | 100.0 |
Access to written procedure concerning work with patients with urinary catheters | 76.0 | 91.7 | 58.3 |
Access in facility to recommendations on treatment of respiratory tract infections | 28.0 | 50.0 | 8.3 |
Access in facility to recommendations on treatment of urinary tract infections | 28.0 | 50.0 | 8.3 |
Access in facility to recommendations on treatment of skin and soft tissues infections | 28.0 | 50.0 | 8.3 |
Surveillance | |||
Healthcare-associated infections surveillance | 52.0 | 100.0 | 0 |
Antibiotic consumption surveillance (yearly report) | 44.0 | 66.7 | 25.0 |
Antimicrobial resistance surveillance | 32.0 | 66.7 | 0 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Baranowska-Tateno, K.; Micek, A.; Gniadek, A.; Wójkowska-Mach, J.; Różańska, A. Healthcare-Associated Infections and Prevention Programs in General Nursing versus Residential Homes—Results of the Point Prevalence Survey in Polish Long-Term Care Facilities. Medicina 2024, 60, 137. https://doi.org/10.3390/medicina60010137
Baranowska-Tateno K, Micek A, Gniadek A, Wójkowska-Mach J, Różańska A. Healthcare-Associated Infections and Prevention Programs in General Nursing versus Residential Homes—Results of the Point Prevalence Survey in Polish Long-Term Care Facilities. Medicina. 2024; 60(1):137. https://doi.org/10.3390/medicina60010137
Chicago/Turabian StyleBaranowska-Tateno, Katarzyna, Agnieszka Micek, Agnieszka Gniadek, Jadwiga Wójkowska-Mach, and Anna Różańska. 2024. "Healthcare-Associated Infections and Prevention Programs in General Nursing versus Residential Homes—Results of the Point Prevalence Survey in Polish Long-Term Care Facilities" Medicina 60, no. 1: 137. https://doi.org/10.3390/medicina60010137
APA StyleBaranowska-Tateno, K., Micek, A., Gniadek, A., Wójkowska-Mach, J., & Różańska, A. (2024). Healthcare-Associated Infections and Prevention Programs in General Nursing versus Residential Homes—Results of the Point Prevalence Survey in Polish Long-Term Care Facilities. Medicina, 60(1), 137. https://doi.org/10.3390/medicina60010137